Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ananda P.K., 2012, Effect of Biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats, Asian Pac. J. Trop. Biomed., 2, 31, 10.1016/S2221-1691(11)60185-8
Annadurai T., 2012, Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats, J. Physiol. Biochem., 68, 307, 10.1007/s13105-011-0142-y
Arulmozhi D.K., 2004, Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: A glance, Indian J. Pharmacol., 36, 217
Atkins R.C., 2010, Diabetic kidney disease: act now or pay later, Acta Physiol. Hung., 97, 52, 10.1556/APhysiol.97.2010.1.6
Badole S.L., 2013, Cycloart-23-ene-3beta, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach, Eur. J. Pharmacol., 698, 470, 10.1016/j.ejphar.2012.10.002
Battell M.L., 1999, Experimental models of diabetes
Bedoya F.J., 1996, N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets, Experientia, 52, 344, 10.1007/BF01919538
Behme M.T., 1995, Nicotinamide and diabetes prevention, Nutr. Rev., 53, 137, 10.1111/j.1753-4887.1995.tb01538.x
Bennett R.A., 1981, Alkylation of DNA in rat tissues following administration of streptozotocin, Cancer Res., 41, 2786
Bolzan A.D., 2002, Genotoxicity of streptozotocin, Mutat. Res., 512, 121, 10.1016/S1383-5742(02)00044-3
Bonner-Weir S., 2000, Islet growth and development in the adult, J. Mol. Endocrinol., 24, 297, 10.1677/jme.0.0240297
Bonner-Weir S., 2000, Life and death of the pancreatic beta cells, Trends Endocrinol. Metab., 11, 375, 10.1016/S1043-2760(00)00305-2
Bonner-Weir S., 2000, Perspective: Postnatal pancreatic beta cell growth, Endocrinology, 141, 1926, 10.1210/endo.141.6.7567
Bonner-Weir S., 2004, Encyclopedia of Gastroenterology
Broca C., 1999, 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties, Am. J. Physiol., 277, E617
Candela S., 1979, Circadian variation of the streptozotocin-diabetogenic effect in mice, Experientia, 35, 1256, 10.1007/BF01963323
Chang K.C., 2006, Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes, Eur. J. Clin. Invest., 36, 1, 10.1111/j.1365-2362.2006.01588.x
Chang K.C., 2006, Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes, Eur. J. Clin. Invest., 36, 528, 10.1111/j.1365-2362.2006.01672.x
Chatzigeorgiou A., 2009, The use of animal models in the study of diabetes mellitus, In Vivo, 23, 245
Chen D., 2005, Development and application of rodent models for type 2 diabetes, Diabetes Obes. Metab., 7, 307, 10.1111/j.1463-1326.2004.00392.x
Chen L., 2012, The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives, Nat. Rev. Endocrinol., 8, 228, 10.1038/nrendo.2011.183
Chi T.C., 2007, Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats, Life Sci., 80, 1713, 10.1016/j.lfs.2007.02.002
Deeds M.C., 2011, Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models, Lab. Anim., 45, 131, 10.1258/la.2010.010090
Eizirik D.L., 1984, Reduced diabetogenic effect of streptozotocin in rats previously adapted to a high-protein, carbohydrate-free diet, Diabetes, 33, 383, 10.2337/diab.33.4.383
Elshal M.F., 2012, Influence of defatted flaxseed diet on insulin sensitivity, vascular permeability and lipid profile in a rat model of type 2 diabetes mellitus, J. Med. Plants Res., 6, 2188
Fierabracci V., 2002, Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes, Endocrine, 19, 177, 10.1385/ENDO:19:2:177
Haluzik M., 2000, The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications, Physiol. Res., 49, S37
Hu Y.Y., 2013, Experimental models of type 2 diabetic nephropathy, Chin. Med. J. (Engl), 126, 574, 10.3760/cma.j.issn.0366-6999.20120675
Hypponen E., 2004, Micronutrients and the risk of type 1 diabetes: vitamin D, vitamin E, and nicotinamide, Nutr. Rev., 62, 340, 10.1111/j.1753-4887.2004.tb00059.x
Irons B.K., 2014, Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated, Diabetes Metab. Syndr. Obes., 7, 15, 10.2147/DMSO.S38753
Islam M.S., 2012, Animal Models in Diabetes Research
Junod A., 1969, Diabetogenic action of streptozotocin: relationship of dose to metabolic response, J. Clin. Invest., 48, 2129, 10.1172/JCI106180
Karunanayake E.H., 1976, Streptozotocin: its excretion and metabolism in the rat, Diabetologia, 12, 483, 10.1007/BF01219512
Kim K.A., 2002, IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis, Diabetologia, 45, 385, 10.1007/s00125-001-0755-8
Krentz A.J., 2005, Oral antidiabetic agents: current role in type 2 diabetes mellitus, Drugs, 65, 385, 10.2165/00003495-200565030-00005
Kuntz E., 2002, Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes, Eur. J. Pharmacol., 448, 253, 10.1016/S0014-2999(02)01937-4
L’abbate A., 2007, Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats, Am. J. Physiol. Heart Circ. Physiol., 293, H3532, 10.1152/ajpheart.00826.2007
Lenzen S., 2008, The mechanisms of alloxan- and streptozotocin-induced diabetes, Diabetologia, 51, 216, 10.1007/s00125-007-0886-7
Li H.T., 2011, Antihyperglycemic effects of baicalin on streptozotocin — nicotinamide induced diabetic rats, Phytother. Res., 25, 189, 10.1002/ptr.3238
Maiese K., 2009, The vitamin nicotinamide: translating nutrition into clinical care, Molecules, 14, 3446, 10.3390/molecules14093446
Masiello P., 2006, Animal models of type 2 diabetes with reduced pancreatic beta-cell mass, Int. J. Biochem. Cell. Biol., 38, 873, 10.1016/j.biocel.2005.09.007
Masiello P., 1977, Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection, Experientia, 33, 1246, 10.1007/BF01922358
Masiello P., 1998, Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide, Diabetes, 47, 224, 10.2337/diab.47.2.224
Murugan P., 2006, Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats, Life Sci., 79, 1720, 10.1016/j.lfs.2006.06.001
Nathan D.M., 2009, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025
Novelli M., 2001, Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes, Mol. Cell. Endocrinol., 175, 57, 10.1016/S0303-7207(01)00400-2
Novelli M., 2004, Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes, Mol. Cell. Endocrinol., 219, 77, 10.1016/j.mce.2004.01.010
Ortiz-Andrade R.R., 2008, Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation, Diabetes Obes. Metab., 10, 1097, 10.1111/j.1463-1326.2008.00869.x
Ortiz P.A., 2002, Role of nitric oxide in the regulation of nephron transport, Am. J. Physiol. Renal. Physiol., 282, F777, 10.1152/ajprenal.00334.2001
Palsamy P., 2010, Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats, Chem. Biol. Interact., 186, 200, 10.1016/j.cbi.2010.03.028
Palsamy P., 2009, Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats, Chem. Biol. Interact., 179, 356, 10.1016/j.cbi.2008.11.008
Palsamy P., 2010, Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats, J. Cell. Physiol., 224, 423, 10.1002/jcp.22138
Palsamy P., 2011, Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling, Biochim. Biophys. Acta, 1812, 719, 10.1016/j.bbadis.2011.03.008
Pandya K.G., 2010, Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide, J. Biomed. Sci., 17, S16, 10.1186/1423-0127-17-S1-S16
Pari L., 2010, Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes, Mol. Cell. Biochem., 341, 109, 10.1007/s11010-010-0442-5
Pari L., 2009, Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats, Life Sci., 85, 830, 10.1016/j.lfs.2009.10.021
Pari L., 2007, Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes, Chem. Biol. Interact., 169, 15, 10.1016/j.cbi.2007.04.010
Pari L., 2006, Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats, Life Sci., 79, 641, 10.1016/j.lfs.2006.02.036
Pari L., 2010, Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats, Biomed. Pharmacother., 64, 477, 10.1016/j.biopha.2010.02.001
Pari L., 2010, Efficacy of naringin on hepatic enzymes of carbohydrate metabolism in streptozotocin-nicotinamide induced type 2 diabetic rats, Int. J. Pharm. Biol. Arch., 1, 280
Pierre W., 2012, Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats, BMC Complement Altern. Med., 12, 264, 10.1186/1472-6882-12-264
Pitkin R.M., 1970, Diabetogenic effects of streptozotocin in rhesus monkeys, Diabetes, 19, 85, 10.2337/diab.19.2.85
Pociot F., 1993, Nicotinamide biological actions and therapeutic potential in diabetes prevention., Diabetologia, 36, 574, 10.1007/BF02743277
Rabbani S.I., 2009, Inhibitory effect of glimepiride on nicotinamide-streptozotocin induced nuclear damages and sperm abnormality in diabetic Wistar rats, Indian J. Exp. Biol., 47, 804
Rajarajeswari N., 2011, Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats, J. Biochem. Mol. Toxicol., 25, 355, 10.1002/jbt.20395
Reed M.J., 2000, A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat, Metabolism, 49, 1390, 10.1053/meta.2000.17721
Rees D.A., 2005, Animal models of diabetes mellitus, Diabet. Med., 22, 359, 10.1111/j.1464-5491.2005.01499.x
Rodrigues B., 1999, Experimental Models of Diabetes
Sharma A.K., 2012, Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats, J. Biomed. Res., 26, 200, 10.7555/JBR.26.20110054
Sheela N., 2013, Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats, Iran J. Kidney Dis., 7, 117
Shirwaikar A., 2006, Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocinnicotinamide induced type-II diabetes mellitus, J. Ethnopharmacol., 107, 285, 10.1016/j.jep.2006.03.012
Siddiqui B.S., 2014, Two new compounds from the aerial parts of Bergenia himalaica Boriss and their anti-hyperglycemic effect in streptozotocin-nicotinamide induced diabetic rats, J. Ethnopharmacol., 152, 561, 10.1016/j.jep.2014.02.002
Srinivasan K., 2007, Animal models in type 2 diabetes research: an overview, Indian J. Med. Res., 125, 451
Su H.C., 2006, Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats, Am. J. Physiol. Endocrinol. Metab., 290, E1339, 10.1152/ajpendo.00487.2005
Szkudelska K., 2014, Adipocyte dysfunction in rats with streptozotocin-nicotinamide-induced diabetes, Int. J. Exp. Pathol., 95, 86, 10.1111/iep.12073
Szkudelski T., 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol. Res., 50, 537
Szkudelski T., 2012, Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model, Exp. Biol. Med. (Maywood), 237, 481, 10.1258/ebm.2012.011372
Taha H., 2014, Upregulation of insulin secretion and downregulation of pro-inflammatory cytokines, oxidative stress and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats by Pseuduvaria monticola bark extract, Food Chem. Toxicol., 66, 295, 10.1016/j.fct.2014.01.054
Tay Y.C., 2005, Can murine diabetic nephropathy be separated from superimposed acute renal failure?, Kidney Int., 68, 391, 10.1111/j.1523-1755.2005.00405.x
Torres-Piedra M., 2010, A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition, Eur. J. Med. Chem., 45, 2606, 10.1016/j.ejmech.2010.02.049